Filing Details
- Accession Number:
- 0001209191-19-047058
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-21 19:40:41
- Reporting Period:
- 2019-08-19
- Accepted Time:
- 2019-08-21 19:40:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1131324 | Genomic Health Inc | GHDX | Services-Medical Laboratories (8071) | 770552594 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1649167 | Frederic Pla | 301 Penobscot Dr. Redwood City CA 94063 | Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-08-19 | 1,251 | $27.48 | 33,142 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-08-19 | 1,251 | $75.00 | 31,891 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) Holding | Disposition | 2019-08-19 | 1,251 | $0.00 | 1,251 | $27.48 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
42,402 | 2027-01-31 | No | 4 | M | Direct |
Footnotes
- Includes an aggregate of 13,381 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on December 10, 2018.
- Represents actual sale price.
- The option became exercisable as to 25% of the shares on January 31, 2018, and becomes exercisable as to 1/48th of the shares each full month thereafter.